BamSEC and AlphaSense Join Forces
Learn More

AIxCrypto Holdings Inc. – Material Contracts

NASDAQ: AIXC    
Share price (3/27/26): $1.15    
Market cap (3/27/26): $26.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 8-K 5 pages Koti Meka 173 Magnet Irvine, Ca 92618 Kmeka@yahoo.com Dear Koti, I Am Pleased to Offer You a Position With AIxCrypto Inc. (The “Company”), as an Chief Financial Officer (CFO) Reporting to Jiawei, Wang, Co-Chief Executive Officer at Our Office Located in Gardena. Position and Duties Salary in Consideration for Your Fractional Services, You Will Receive an Annual Base Salary of $150,000, Payable in Accordance With the Company’s Standard Payroll Practices. Bonus
12/34/56
EX-10.4
from 8-K 2 pages [Company Letterhead: Alxcrypto Holdings, Inc.]
12/34/56
EX-10.3
from 8-K ~1 page Reference Is Made to the Appointment Today of Kevin A. Richardson II as Co-Chief Executive Officer of Qualigen Therapeutics, Inc. (The “Company”), Pursuant to the Lead Investor Agreement Dated as of September 19, 2025 Between the Company and Faraday Future Intelligent Electric Inc
12/34/56
EX-10.2
from 8-K 24 pages [Pursuant to Item 601(b)(2)(ii) of Regulation S-K, Certain Terms to This Exhibit Have Been Omitted as They Are Both Not Material and of the Type That the Registrant Treats as Private or Confidential. a Copy of Unredacted Copy of the Exhibit Will Be Furnished Supplementally to the SEC Upon Request.] Employment Agreement
12/34/56
EX-10.1
from 8-K 4 pages [Pursuant to Item 601(b)(2)(ii) of Regulation S-K, Certain Terms to This Exhibit Have Been Omitted as They Are Both Not Material and of the Type That the Registrant Treats as Private or Confidential. a Copy of Unredacted Copy of the Exhibit Will Be Furnished Supplementally to the SEC Upon Request.] Advisor Agreement
12/34/56
EX-10.3
from 8-K 39 pages Securities Purchase Agreement Dated as of January 30, 2026 Among Faraday Future Intelligent Electric Inc., as the Issuer and Gold King Arthur Holding Limited Annexes, Exhibits and Schedules
12/34/56
EX-10.2
from 8-K 12 pages Entrusted Investment Agreement
12/34/56
EX-10.1
from 8-K 8 pages Consulting Services Agreement
12/34/56
EX-10.6
from 8-K 12 pages Placement Agency Agreement
12/34/56
EX-10.5
from 8-K 10 pages Voting Support Agreement
12/34/56
EX-10.4
from 8-K 5 pages Capital Market Advisory Agreement
12/34/56
EX-10.3
from 8-K 8 pages Lead Investor Agreement
12/34/56
EX-10.2
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 44 pages Form of Subscription Agreement
12/34/56
EX-10.2
from 8-K 3 pages Amendment No. 1 to Amended and Restated Secured Demand Promissory Note
12/34/56
EX-10.1
from 8-K 15 pages Amended and Restated Secured Demand Promissory Note
12/34/56
EX-10.2
from 8-K 17 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 35 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K/A 17 pages Qualigen Therapeutics, Inc. Board of Directors Agreement
12/34/56
EX-10.1
from 8-K 17 pages Qualigen Therapeutics, Inc. Board of Directors Agreement
12/34/56